Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
International Severe Acute Respiratory and Emerging Infections (ISARIC) Report 27 April 2020. International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). Available at: https://emergencymedicinecases.com/ (accessed 23rd April 2021).
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–848. DOI: 10.1007/s00134-020-05991-x.
Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 2020;26:1395–1399. DOI: 10.1016/j.cmi.2020.06.025.
Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection, and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Inf 2020;26:1622–1629. DOI: 10.1016/j.cmi.2020.07.016.
Vaughn VM, Gandhi T, Petty LA, Patel PK, Prescott HC, Malani AN, et al. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study. Clin Infect Dis 2020;2020:ciaa1239. DOI: 10.1093/cid/ciaa1239.
Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal co-infections in COVID-19 patients hospitalized during the New York City Pandemic Surge. Infect Control Hosp Epidemiol 42(1):84-88. DOI: 10.1017/ice.2020.368.
Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021–1028. DOI: 10.1515/cclm-2020-0369.
Pulia MS, Wolf I, Schulz LT, Pop-Vicas A, Schwei RJ, Lindenauer PK. COVID-19: an emerging threat to antibiotic stewardship in the emergency department. West J Emerg Med 2020;21:1283–1286. DOI: 10.5811/westjem.2020.7.48848.
Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA 2020;323:1839–1841. DOI: 10.1001/jama.2020.4914.
Buetti N, Mazzuchelli T, Priore EL, Balmelli C, Llamas M, Pallanza M, et al. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19. J Infect 2020;81:e148–e149. DOI: 10.1016/j.jinf.2020.06.004.
Guaraldi G, Meschiari M, Cozzi-Lepri A. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol 2020;2020:E474–E484. DOI: 10.1016/S2665-9913(20)30173-9.
Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the intensive care unit. Crit Care Med 2012;40:3277–3282. DOI: 10.1097/CCM.0b013e318270e771.
Williams P, McWilliams C, Soomro K. The dynamics of procalcitonin in COVID-19 patients admitted to intensive care unit- a multi-center cohort study in the south west of England, UK. J Infect 2021;4:31. DOI: 10.1016/j.jinf.2021.03.011.
Van Berkel M, Kox M, Frenzel T, Pickkers P, Schouten J. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? Crit Care 2020;24:600. DOI: 10.1186/s13054-020-03291-w.
Williams EJ, Mair L, de Silva TI, Green DJ, House P, Cawthron K, et al. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-Cov-2 infection: a retrospective cohort study. J Hosp Infect 2021;110:103–107. DOI: 10.1016/j.jhin.2021.01.006.
Dhesi Z, Enne VI, Brealey D. Organisms causing secondary pneumonia in COVID-19 patients in 5 UK ICUs as detected with the film Array test. Available at: https://www.medrxiv.org/content/10.1101/2020.06.22.20131573v1.full.pdf.
Kayarat B, Khanna P, Sarkar S. Superadded Coinfections and Antibiotic Resistance in the Context of COVID-19: Where do We stand? Indian J Crit Care Med 2021;25(6):698–702.